Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis P Mossuz, F Girodon, M Donnard, V Latger-Cannard, I Dobo, N Boiret, ... haematologica 89 (10), 1194-1198, 2004 | 231 | 2004 |
CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells MC Jacob, L Chaperot, P Mossuz, J Feuillard, F Valensi, D Leroux, ... haematologica 88 (8), 941-955, 2003 | 206 | 2003 |
Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications E Pourcelot, C Trocme, J Mondet, S Bailly, B Toussaint, P Mossuz Experimental hematology 42 (5), 360-368, 2014 | 156 | 2014 |
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution X Cabagnols, JP Defour, V Ugo, JC Ianotto, P Mossuz, J Mondet, ... Leukemia 29 (1), 249-252, 2015 | 153 | 2015 |
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition R Chaligné, C Tonetti, R Besancenot, L Roy, C Marty, P Mossuz, ... Leukemia 22 (8), 1557-1566, 2008 | 150 | 2008 |
The IgG Fc receptor, FcγRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma MB Callanan, P Le Baccon, P Mossuz, S Duley, C Bastard, R Hamoudi, ... Proceedings of the National Academy of Sciences 97 (1), 309-314, 2000 | 108 | 2000 |
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients E Nicolas, C Ramus, S Berthier, M Arlotto, A Bouamrani, C Lefebvre, ... Leukemia 25 (1), 57-65, 2011 | 75 | 2011 |
Circulating cytokine levels as markers of inflammation in Philadelphia negative myeloproliferative neoplasms: diagnostic and prognostic interest J Mondet, K Hussein, P Mossuz Mediators of inflammation 2015 (1), 670580, 2015 | 69 | 2015 |
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study D Luque Paz, J Riou, E Verger, B Cassinat, A Chauveau, JC Ianotto, ... Blood Advances 5 (5), 1442-1451, 2021 | 62 | 2021 |
Deciphering the impact of early-life exposures to highly variable environmental factors on foetal and child health: design of SEPAGES couple-child cohort S Lyon-Caen, V Siroux, J Lepeule, P Lorimier, P Hainaut, P Mossuz, ... International Journal of Environmental Research and Public Health 16 (20), 3888, 2019 | 52 | 2019 |
Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera I Dobo, M Donnard, F Girodon, P Mossuz, N Boiret, R Boukhari, ... The Hematology Journal 5 (2), 161-167, 2004 | 52 | 2004 |
Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts J Mondet, S Chevalier, P Mossuz Molecules 26 (5), 1323, 2021 | 51 | 2021 |
TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms M Kovačić, O Mitrović-Ajtić, B Beleslin-Čokić, D Djikić, T Subotički, ... Cellular Oncology 41, 541-553, 2018 | 49 | 2018 |
Iron for proliferation of cell lines and hematopoietic progenitors: nailing down the intracellular functional iron concentration E Pourcelot, M Lénon, N Mobilia, JY Cahn, J Arnaud, E Fanchon, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (7), 1596-1605, 2015 | 47 | 2015 |
Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia I Dobo, P Mossuz, L Campos, F Girodon, A Allegraud, V Latger-Cannard, ... The Hematology Journal 2 (6), 396-403, 2001 | 45 | 2001 |
Expression and function of receptors for extracellular matrix molecules in the differentiation of human megakaryocytes in vitro P Mossuz, A Schweitzer, A Molla, R Berthier British journal of haematology 98 (4), 819-827, 1997 | 43 | 1997 |
Effects of two sex steroids (17β estradiol and testosterone) on proliferation and clonal growth of the human monoblastic leukemia cell line, U937 P Mossuz, F Cousin, A Castinel, M Chauvet, MF Sotto, B Polack, JJ Sotto, ... Leukemia research 22 (11), 1063-1072, 1998 | 41 | 1998 |
The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker C Lo Presti, F Fauvelle, MC Jacob, J Mondet, P Mossuz Blood Advances 5 (1), 156-166, 2021 | 40 | 2021 |
Microarray and proteomic analyses of myeloproliferative neoplasms with a highlight on the mTOR signaling pathway VP Čokić, P Mossuz, J Han, N Socoro, BB Beleslin-Čokić, O Mitrović, ... PLoS One 10 (8), e0135463, 2015 | 39 | 2015 |
A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia I Dobo, N Boiret, E Lippert, F Girodon, P Mossuz, M Donnard, L Campos, ... Haematologica 89 (10), 1207-1212, 2004 | 33 | 2004 |